PatSnap offers the following webinar:
IP and R&D trends and challenges in biological sequence
Nov. 4, 2020 at 11:00 AM EST | 4:00 PM CET
Registration link
In this webinar we'll explore how innovators rise to the challenge with comprehensive sequence searches.
… The prior art, containing patents for biological gene sequences, and the claims generally include descriptions of gene sequences as a form of protection of DNA, RNA, other nucleotides and proteins. These patents are always claimed with in relation to the sequence upon which the said drug acts. This is mostly with respect to a disease which occurs as a result of sequence mutation or a disease which the drug is used to treat for and acts upon the sequence mentioned in the claim. So metadata associated to a sequence claimed in the patents has gained more significance than before for both research and FTO perspective.
This webinar will show how AI has helped to shift the approach to sequence searching to the next level.
Your hosts Meagan Botnick, Account Executive and Edward Vineall, Senior Account Executive will be looking at AI in sequence searching, followed by a discussion on Prior Art and how it has contributed to Drug Discovery and made a difference within IP & R&D teams in the way they go about sequence searching today.
https://info.patsnap.com/ip-and-rd-trends-and-challenges-in-biological-sequence
|
|
Note: See recording at BrightTalk (38:01, Sep. 28, 2020) of PatSnap webinar with the same title and different speakers,discussing use of AI in sequence searching in PatSnap Bio, starting at 23:48. See other information related PatSnap Bio searching at the earlier Sept. 28, 2020 PIUG-DF post.
|
Search
Community
Job Board
